Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Revenue (2020 - 2025)

Agilon Health (AGL) has disclosed Revenue for 6 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 3.09% year-over-year to $1.6 billion, compared with a TTM value of $5.9 billion through Dec 2025, down 2.11%, and an annual FY2025 reading of $5.9 billion, down 2.11% over the prior year.
  • Revenue was $1.6 billion for Q4 2025 at Agilon Health, up from $1.4 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.6 billion in Q1 2024 and bottomed at $150.8 million in Q4 2021.
  • Average Revenue over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2023.
  • The sharpest move saw Revenue crashed 53.02% in 2021, then surged 185.59% in 2023.
  • Year by year, Revenue stood at $150.8 million in 2021, then skyrocketed by 145.18% to $369.8 million in 2022, then surged by 185.59% to $1.1 billion in 2023, then skyrocketed by 44.16% to $1.5 billion in 2024, then increased by 3.09% to $1.6 billion in 2025.
  • Business Quant data shows Revenue for AGL at $1.6 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.